BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4452013)

  • 1. [Combination of chemotherapy of malignant tumours, BCG vaccination with in particular of the ovaries (author's transl)].
    Lédr J
    Cesk Gynekol; 1974 Mar; 39(2):142-3. PubMed ID: 4452013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results obtained with directed chemotherapy of ovarian cancer (author's transl)].
    Dvorák O
    Cesk Gynekol; 1976 Dec; 41(10):717-8. PubMed ID: 1009601
    [No Abstract]   [Full Text] [Related]  

  • 3. [New developments in the chemotherapy of ovarian cancer (author's transl)].
    Brunner KW; Goldhirsch A; Joss R
    Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].
    Lhommé C; Ray-Coquard I; Guastalla JP; Bataillard A; Thomas L; Bonnier P; Dargent D; Dohollou N; Ganem G; Lefranc JP; Misset JL; Rixe O; Tchiknavorian X; Tournigand C; Villet R; Bachelot T; Kerbrat P; Fervers B; Basuyau JP; Cohen-Solal-Le Nir C; Morice P; Duvillard P; Voog E; ; ; ; ; ;
    Bull Cancer; 2004; 91(7-8):609-20. PubMed ID: 15381451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian cancer: role of medical treatment].
    Cappelaere P; Chauvergne J; Guerrin J
    Bull Cancer; 1982; 69(3):284-91. PubMed ID: 7126897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and future developments in chemotherapy of advanced epithelial ovarian cancers (author's transl)].
    Szepesi T
    Wien Klin Wochenschr; 1981 Apr; 93(8):251-5. PubMed ID: 6266166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryonic antigen (C.E.A.). Its value in the care of malignant tumours of the ovary (author's transl)].
    Laffargue F; Thomas M; Piana L; Gibert-Blondeau D; Bougrand P; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(5):435-42. PubMed ID: 7320442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levels of serum immunoglobulins in cases of progressive malignant ovarian diseases (author's transl)].
    Laurová L; Cízková J; Jandová A; Koprivová H; Skoda V
    Cesk Gynekol; 1976 Dec; 41(10):725-6. PubMed ID: 1009605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant tumours (author's transl)].
    Karrer K
    Wien Klin Wochenschr; 1978 Dec; 90(24):849-56. PubMed ID: 369149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the management of 552 malignant tumours of the ovaries (author's transl)].
    Heidenreich W; Mestwerdt W; Török M
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):565-72. PubMed ID: 4849635
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tactics of the cytostatic treatment in ovarian cancers (author's transl)].
    Budinská B
    Cesk Gynekol; 1976 Dec; 41(10):722-3. PubMed ID: 1009603
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy for gynecologic malignancies.
    Cohen CJ; Deppe G
    Prog Clin Biol Res; 1981; 70():371-4. PubMed ID: 7031696
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the role of chemotherapy following radical surgery for cilioepithelial tumors of the ovaries].
    Nechaeva ID; Kotova DG; Livshits MA
    Vopr Onkol; 1972; 18(2):32-4. PubMed ID: 4622343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical situation and therapy of ovarian carcinoma at Gynaecological Hospital of Jena University, between 1967 and 1976 (author's transl)].
    Meinhold P; Sommer H; Nöschel H; Günther M
    Zentralbl Gynakol; 1981; 103(21):1280-8. PubMed ID: 7324630
    [No Abstract]   [Full Text] [Related]  

  • 15. [BCG immunotherapy in children with acute lymphocytic leukemia in continuous remission after 3 years of intensive chemotherapy (protocol C-70) (author's transl)].
    Ortega JJ; Javier G
    Med Clin (Barc); 1982 Mar 1-15; 78(5):183-8. PubMed ID: 6952060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic results of advanced malignant ovarian tumours].
    Taubert W; Prager W
    Radiobiol Radiother (Berl); 1973; 14(1):11-6. PubMed ID: 4689204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies into dependence of sensitivity of cytostatics on overlap index of ovarian cancer in cell cultures (author's transl)].
    Schindler C
    Zentralbl Gynakol; 1982; 104(3):156-9. PubMed ID: 7043954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined chemotherapy in malignant tumours. Theoretical principles and general rules of practical use (author's transl)].
    Klener P
    Cas Lek Cesk; 1978 Apr; 117(16):481-5. PubMed ID: 657214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience from palliative chemotherapy for advanced ovarian carcinoma - progress report on hospital with outpatient department at district level (author's transl)].
    Tilch G; Miesel U; Koall E
    Zentralbl Gynakol; 1982; 104(3):160-7. PubMed ID: 6177126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of the uric acid concentration in the blood-serum during cytostatic therapy of ovarian cancer (author's transl)].
    Kudela M; Podivínský R
    Cesk Gynekol; 1979 May; 44(4):282-4. PubMed ID: 445608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.